HLA genotype and response to nivolumab therapy in relapsed refractory primary mediastinal B-cell lymphoma

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Yassin, R., Hajeer, A., Alshieban, S., Syed, G., Alahmari, B., Alhejazi, A., … Damlaj, M. (2019, February 1). HLA genotype and response to nivolumab therapy in relapsed refractory primary mediastinal B-cell lymphoma. Current Research in Translational Medicine. Elsevier Masson SAS. https://doi.org/10.1016/j.retram.2018.11.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free